KETOTIFEN FUMARATE

KETOTIFEN FUMARATE was reported 6578 times

KETOTIFEN FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUSCLE TENSION DYSPHONIA 16 0.2000
1 OPHTHALMIC FLUID DRAINAGE 2 0.0690
2 KAPOSI'S VARICELLIFORM ERUPTION 3 0.0682
3 MASTOCYTOSIS 23 0.0486
4 PERFUME SENSITIVITY 27 0.0475
5 INSTILLATION SITE PAIN 113 0.0456
6 TREATMENT FAILURE 2496 0.0301
7 INSTILLATION SITE IRRITATION 35 0.0296
8 CARNITINE DECREASED 2 0.0244
9 MECHANICAL URTICARIA 11 0.0235
10 INSTILLATION SITE SWELLING 4 0.0229
11 INSTILLATION SITE LACRIMATION 5 0.0207
12 LYMPHATIC FISTULA 2 0.0200
13 VASCULAR ACCESS SITE COMPLICATION 5 0.0198
14 IMMUNISATION REACTION 14 0.0194
15 INSTILLATION SITE PRURITUS 7 0.0186
16 VACCINATION COMPLICATION 14 0.0171
17 MAST CELL ACTIVATION SYNDROME 19 0.0135
18 INSTILLATION SITE ERYTHEMA 7 0.0133
19 RESTRICTIVE PULMONARY DISEASE 14 0.0119
20 MITRAL VALVE SCLEROSIS 2 0.0116
21 EYE IRRITATION 645 0.0112
22 REACTION TO PRESERVATIVES 9 0.0111
23 ALLERGY TO PLANTS 5 0.0109
24 ORAL PRURITUS 24 0.0104
25 TRYPTASE INCREASED 7 0.0098
26 GINGIVAL OPERATION 2 0.0091
27 CONJUNCTIVITIS ALLERGIC 13 0.0088
28 EYE ALLERGY 13 0.0084
29 EYELID SKIN DRYNESS 10 0.0082
30 KERATOCONJUNCTIVITIS SICCA 3 0.0082
31 LOWER RESPIRATORY TRACT INFECTION VIRAL 4 0.0079
32 HAEMORRHAGIC DIATHESIS 28 0.0079
33 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0078
34 INSTILLATION SITE DISCHARGE 2 0.0076
35 CHEMICAL BURNS OF EYE 2 0.0072
36 MOUTH BREATHING 3 0.0069
37 CHRONIC SPONTANEOUS URTICARIA 8 0.0069
38 HYPOAESTHESIA EYE 4 0.0068
39 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
40 DYSPHORIA 33 0.0065
41 EYE PRURITUS 218 0.0065
42 EYELID PAIN 13 0.0064
43 BLOOD CREATINE PHOSPHOKINASE DECREASED 2 0.0061
44 FOOD INTOLERANCE 22 0.0060
45 DYSPHEMIA 26 0.0059
46 ARTHRITIS INFECTIVE 27 0.0058
47 SUPERFICIAL INJURY OF EYE 6 0.0055
48 CARBOHYDRATE ANTIGEN 15-3 INCREASED 4 0.0053
49 VERTIGO POSITIONAL 9 0.0051
50 EYE BURNS 3 0.0051
51 SKIN WARM 29 0.0050
52 INCISION SITE IMPAIRED HEALING 2 0.0050
53 EYE PAIN 280 0.0050
54 OCULAR HYPERAEMIA 230 0.0048
55 APPETITE DISORDER 32 0.0048
56 EXPOSURE TO SARS-COV-2 8 0.0047
57 DACRYOSTENOSIS ACQUIRED 6 0.0046
58 FOREIGN BODY SENSATION IN EYES 29 0.0045
59 ALLERGIC REACTION TO EXCIPIENT 9 0.0045
60 INFUSION SITE URTICARIA 3 0.0045
61 EYE DISCHARGE 45 0.0043
62 TENDON DISORDER 28 0.0043
63 LACRIMATION DECREASED 2 0.0042
64 FOREIGN BODY IN EYE 4 0.0042
65 EYELID MARGIN CRUSTING 12 0.0041
66 INTRAOCULAR LENS IMPLANT 2 0.0040
67 INJURY CORNEAL 2 0.0038
68 EYELID EXFOLIATION 3 0.0038
69 INFUSION SITE CELLULITIS 2 0.0038
70 ERYTHEMA OF EYELID 20 0.0037
71 EYE INFLAMMATION 35 0.0037
72 ASTHENOPIA 20 0.0036
73 OCULAR TOXICITY 4 0.0036
74 EYE INFECTION BACTERIAL 2 0.0036
75 INFECTED BITE 3 0.0035
76 EYELIDS PRURITUS 11 0.0035
77 OESOPHAGEAL IRRITATION 2 0.0034
78 EYELID OEDEMA 40 0.0034
79 DEVICE MAINTENANCE ISSUE 2 0.0034
80 CERUMEN IMPACTION 3 0.0033
81 TENDERNESS 34 0.0033
82 METAMORPHOPSIA 6 0.0033
83 EXPIRED DRUG ADMINISTERED 16 0.0032
84 LIPOHYPERTROPHY 2 0.0032
85 EYELID IRRITATION 8 0.0032
86 EXOSTOSIS 29 0.0032
87 CHALAZION 2 0.0031
88 DEVICE RELATED THROMBOSIS 3 0.0030
89 ABNORMAL SENSATION IN EYE 13 0.0030
90 PERIORBITAL SWELLING 17 0.0030
91 EYE COLOUR CHANGE 3 0.0029
92 CHRONIC SINUSITIS 11 0.0029
93 EPISCLERITIS 2 0.0029
94 GENITAL SWELLING 2 0.0029
95 LACRIMATION INCREASED 87 0.0029
96 SWELLING OF EYELID 18 0.0029
97 SKIN REACTION 39 0.0028
98 PHOTOPHOBIA 52 0.0028
99 BLEPHARITIS 11 0.0027
100 EYE SWELLING 102 0.0027
101 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
102 AORTIC VALVE SCLEROSIS 2 0.0027
103 OCULAR DISCOMFORT 30 0.0027
104 OROPHARYNGEAL DISCOMFORT 24 0.0027
105 MULTIPLE DRUG THERAPY 2 0.0027
106 ASPIRATION PLEURAL CAVITY 2 0.0026
107 ALLERGIC COUGH 2 0.0026
108 PATIENT DISSATISFACTION WITH TREATMENT 5 0.0026
109 INFECTION PARASITIC 2 0.0026
110 HEAT EXHAUSTION 2 0.0025
111 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 4 0.0024
112 FOOT DEFORMITY 26 0.0023
113 INFUSION SITE IRRITATION 3 0.0023
114 LUNG HYPERINFLATION 2 0.0023
115 DRY EYE 114 0.0023
116 HEREDITARY ANGIOEDEMA 24 0.0022
117 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
118 SCRATCH 23 0.0022
119 EYELID DISORDER 5 0.0022
120 BLOOD BICARBONATE DECREASED 4 0.0021
121 CARCINOEMBRYONIC ANTIGEN INCREASED 4 0.0021
122 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
123 EYELID RASH 2 0.0020
124 STRIDOR 6 0.0020
125 EXCESSIVE EYE BLINKING 3 0.0020
126 MUCOSAL ULCERATION 2 0.0020
127 OSTEITIS 5 0.0020
128 MEAN CELL VOLUME INCREASED 5 0.0019
129 SEASONAL ALLERGY 27 0.0019
130 INNER EAR DISORDER 2 0.0019
131 ANKLE FRACTURE 29 0.0019
132 IDIOPATHIC URTICARIA 2 0.0019
133 INFUSION SITE BRUISING 4 0.0019
134 CORNEAL DISORDER 4 0.0018
135 PARAESTHESIA ORAL 26 0.0018
136 AORTIC DILATATION 2 0.0018
137 EAR PAIN 35 0.0018
138 CORNEAL OEDEMA 4 0.0018
139 CORTISOL DECREASED 2 0.0017
140 SNEEZING 39 0.0017
141 INFUSION SITE DISCHARGE 3 0.0017
142 EAR PRURITUS 6 0.0017
143 INGROWING NAIL 4 0.0017
144 NASAL OEDEMA 3 0.0017
145 HORDEOLUM 7 0.0016
146 NASAL PRURITUS 2 0.0016
147 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
148 SYNOVITIS 28 0.0016
149 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
150 PARALYSIS 22 0.0015
151 MULTIPLE ALLERGIES 12 0.0015
152 FOOT FRACTURE 29 0.0015
153 NEPHROGENIC ANAEMIA 7 0.0015
154 OSTEOARTHRITIS 64 0.0015
155 PYELONEPHRITIS 13 0.0015
156 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
157 MUSCLE TIGHTNESS 24 0.0015
158 SKIN WRINKLING 4 0.0015
159 HYPERPARATHYROIDISM 3 0.0015
160 THINKING ABNORMAL 27 0.0014
161 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
162 DISCHARGE 2 0.0014
163 PRE-EXISTING CONDITION IMPROVED 9 0.0014
164 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 2 0.0014
165 PHARYNGEAL SWELLING 14 0.0014
166 BLEPHAROSPASM 9 0.0014
167 ORAL PAIN 32 0.0014
168 PAPULE 10 0.0014
169 CONNECTIVE TISSUE DISORDER 2 0.0014
170 NOROVIRUS INFECTION 2 0.0014
171 DRUG TOLERANCE 7 0.0014
172 NONINFECTIVE GINGIVITIS 2 0.0014
173 MONOCYTE COUNT INCREASED 5 0.0014
174 DARK CIRCLES UNDER EYES 2 0.0014
175 RHINITIS ALLERGIC 6 0.0013
176 IMPETIGO 2 0.0013
177 EYE INJURY 4 0.0013
178 INFERTILITY FEMALE 2 0.0013
179 EYE DISORDER 42 0.0013
180 INFUSION SITE PRURITUS 4 0.0013
181 INHIBITORY DRUG INTERACTION 2 0.0013
182 EOSINOPHIL COUNT DECREASED 3 0.0013
183 ANAPHYLACTIC REACTION 69 0.0012
184 PRODUCT PACKAGING CONFUSION 3 0.0012
185 EXPIRED PRODUCT ADMINISTERED 41 0.0012
186 DEVICE INFUSION ISSUE 3 0.0012
187 ANGIOEDEMA 52 0.0012
188 CARBOHYDRATE ANTIGEN 125 INCREASED 4 0.0012
189 TEMPERATURE INTOLERANCE 12 0.0012
190 EYE INFECTION 13 0.0012
191 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
192 CONJUNCTIVITIS 21 0.0011
193 BREAST CYST 2 0.0011
194 OBESITY 18 0.0011
195 BLOOD PHOSPHORUS INCREASED 3 0.0011
196 ESSENTIAL HYPERTENSION 2 0.0011
197 CONTRAST MEDIA ALLERGY 2 0.0011
198 VISION BLURRED 146 0.0011
199 VAGINAL INFECTION 5 0.0011
200 NARCOLEPSY 2 0.0011
201 HYPOPROTEINAEMIA 2 0.0011
202 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
203 OSTEOPOROTIC FRACTURE 2 0.0010
204 FIBULA FRACTURE 3 0.0010
205 MOUTH SWELLING 6 0.0010
206 HEPATIC MASS 2 0.0010
207 FOOD ALLERGY 8 0.0010
208 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
209 INTRAOCULAR PRESSURE INCREASED 13 0.0010
210 BREATH SOUNDS ABNORMAL 5 0.0010
211 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
212 AUTOIMMUNE HEPATITIS 7 0.0010
213 ATYPICAL PNEUMONIA 3 0.0010
214 WHEEZING 59 0.0010
215 RHINITIS 8 0.0010
216 SKIN DISORDER 33 0.0010
217 IRITIS 3 0.0010
218 GENERALISED OEDEMA 12 0.0010
219 DERMATITIS CONTACT 11 0.0010
220 INFUSION SITE EXTRAVASATION 6 0.0010
221 MIDDLE INSOMNIA 18 0.0010
222 HYPERSENSITIVITY 178 0.0010
223 INFUSION SITE SWELLING 6 0.0010
224 PHOTOPSIA 6 0.0009
225 EYE CONTUSION 2 0.0009
226 PRODUCT DELIVERY MECHANISM ISSUE 5 0.0009
227 PRODUCT RESIDUE PRESENT 5 0.0009
228 DIABETIC NEPHROPATHY 2 0.0009
229 MIDDLE EAR EFFUSION 2 0.0009
230 ACCIDENT AT WORK 2 0.0009
231 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
232 BLISTER 50 0.0009
233 GASTRIC POLYPS 2 0.0009
234 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
235 ROSACEA 4 0.0009
236 RHINORRHOEA 54 0.0008
237 WOUND 23 0.0008
238 PRODUCT CONTAINER ISSUE 7 0.0008
239 PSORIATIC ARTHROPATHY 33 0.0008
240 VIRAL INFECTION 27 0.0008
241 INJECTION SITE EXTRAVASATION 10 0.0008
242 URTICARIA 135 0.0008
243 THROAT CLEARING 3 0.0008
244 VEIN DISORDER 4 0.0008
245 PARANASAL SINUS DISCOMFORT 3 0.0008
246 ENDODONTIC PROCEDURE 2 0.0008
247 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
248 GASTRIC INFECTION 3 0.0008
249 ANGLE CLOSURE GLAUCOMA 2 0.0008
250 OESOPHAGEAL ULCER 3 0.0008
251 AORTIC ARTERIOSCLEROSIS 2 0.0008
252 GASTROENTERITIS VIRAL 14 0.0008
253 CATHETER SITE PAIN 2 0.0008
254 DYSPHAGIA 72 0.0008
255 NASAL DISORDER 2 0.0008
256 ASTHMA 85 0.0008
257 EYE HAEMORRHAGE 10 0.0007
258 INTESTINAL OBSTRUCTION 28 0.0007
259 BURNING SENSATION 52 0.0007
260 EAR CONGESTION 2 0.0007
261 PRODUCT PACKAGING ISSUE 7 0.0007
262 EOSINOPHILIC OESOPHAGITIS 2 0.0007
263 NECK PAIN 40 0.0007
264 VITREOUS FLOATERS 7 0.0007
265 BODY TEMPERATURE DECREASED 7 0.0007
266 LIGAMENT SPRAIN 7 0.0007
267 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
268 OEDEMA 38 0.0007
269 DRUG INEFFECTIVE 920 0.0007
270 HEART VALVE INCOMPETENCE 2 0.0007
271 EYELID PTOSIS 7 0.0007
272 VISUAL IMPAIRMENT 85 0.0007
273 ADVERSE REACTION 9 0.0007
274 POOR VENOUS ACCESS 7 0.0007
275 GLAUCOMA 13 0.0007
276 CATARACT OPERATION 4 0.0007
277 SINUS HEADACHE 4 0.0007
278 FACIAL PAIN 6 0.0007
279 HYPERLIPIDAEMIA 8 0.0007
280 BLOOD CULTURE POSITIVE 2 0.0007
281 SPEECH DISORDER 35 0.0007
282 HYPOAESTHESIA ORAL 10 0.0007
283 EMERGENCY CARE 2 0.0007
284 EMBOLISM VENOUS 2 0.0007
285 SYNOVIAL CYST 3 0.0006
286 SCOLIOSIS 4 0.0006
287 NEPHROPATHY 6 0.0006
288 INTERSTITIAL LUNG DISEASE 31 0.0006
289 BLOOD CREATININE DECREASED 2 0.0006
290 SPINAL COLUMN STENOSIS 3 0.0006
291 PRODUCT USE COMPLAINT 10 0.0006
292 SKIN ABRASION 3 0.0006
293 IRIDOCYCLITIS 2 0.0006
294 DYSPHONIA 37 0.0006
295 BLADDER PAIN 2 0.0006
296 MYDRIASIS 8 0.0006
297 CUSHINGOID 2 0.0006
298 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
299 SENSATION OF FOREIGN BODY 5 0.0006
300 FACE OEDEMA 10 0.0006
301 WRONG PRODUCT ADMINISTERED 4 0.0006
302 PRURITUS 227 0.0006
303 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
304 OSTEOPOROSIS 24 0.0006
305 BLOOD PRESSURE INCREASED 89 0.0006
306 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
307 BONE PAIN 34 0.0006
308 BLOOD CALCIUM INCREASED 5 0.0006
309 CONJUNCTIVAL HYPERAEMIA 2 0.0006
310 GASTROINTESTINAL INFECTION 5 0.0006
311 CHEST DISCOMFORT 57 0.0006
312 GINGIVITIS 3 0.0006
313 RASH PRURITIC 30 0.0006
314 TONGUE DISORDER 4 0.0006
315 TIC 3 0.0005
316 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 99 0.0005
317 ASTHMATIC CRISIS 2 0.0005
318 JOINT SWELLING 66 0.0005
319 MOUTH HAEMORRHAGE 4 0.0005
320 SWOLLEN TONGUE 17 0.0005
321 INFUSION SITE PAIN 7 0.0005
322 ANAPHYLACTIC SHOCK 14 0.0005
323 CONTUSION 52 0.0005
324 ARTHROPOD BITE 4 0.0005
325 MACULAR OEDEMA 3 0.0005
326 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
327 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
328 LOSS OF CONTROL OF LEGS 2 0.0005
329 MUSCULOSKELETAL STIFFNESS 46 0.0005
330 RASH ERYTHEMATOUS 25 0.0005
331 HAEMOLYSIS 4 0.0005
332 THERAPY PARTIAL RESPONDER 8 0.0005
333 EPIGASTRIC DISCOMFORT 2 0.0005
334 BRAIN FOG 8 0.0005
335 TRICUSPID VALVE INCOMPETENCE 4 0.0005
336 OESOPHAGEAL CANDIDIASIS 2 0.0005
337 APHONIA 7 0.0005
338 SYMPTOM RECURRENCE 3 0.0005
339 OBSTRUCTION 2 0.0005
340 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
341 ARTHRITIS 39 0.0005
342 FUNGAL SKIN INFECTION 2 0.0005
343 TOOTH ABSCESS 5 0.0005
344 INITIAL INSOMNIA 5 0.0005
345 ERYTHEMA 100 0.0005
346 ILLNESS 50 0.0005
347 SPINAL COMPRESSION FRACTURE 4 0.0005
348 PRODUCT QUALITY ISSUE 65 0.0005
349 WEIGHT FLUCTUATION 5 0.0005
350 CONDITION AGGRAVATED 145 0.0005
351 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
352 INFUSION SITE ERYTHEMA 4 0.0005
353 SKIN PLAQUE 4 0.0005
354 MOBILITY DECREASED 34 0.0005
355 ABDOMINAL DISCOMFORT 79 0.0005
356 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
357 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
358 ABSCESS LIMB 2 0.0005
359 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
360 DRY SKIN 62 0.0005
361 HERPES SIMPLEX 3 0.0005
362 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
363 SKIN SWELLING 4 0.0005
364 MONOPLEGIA 2 0.0005
365 BONE CANCER 2 0.0005
366 SINUSITIS 47 0.0005
367 PRODUCT PREPARATION ISSUE 3 0.0005
368 GINGIVAL SWELLING 2 0.0005
369 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
370 EAR INFECTION 12 0.0005
371 BREAST MASS 3 0.0004
372 PRODUCT LABEL ISSUE 3 0.0004
373 MITRAL VALVE INCOMPETENCE 5 0.0004
374 PRODUCT AVAILABILITY ISSUE 10 0.0004
375 END STAGE RENAL DISEASE 8 0.0004
376 ONYCHOCLASIS 3 0.0004
377 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
378 LOCALISED OEDEMA 2 0.0004
379 MADAROSIS 5 0.0004
380 MIGRAINE 41 0.0004
381 HALLUCINATION 32 0.0004
382 HEPATOCELLULAR INJURY 6 0.0004
383 ENDOMETRIOSIS 2 0.0004
384 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
385 FAECES SOFT 3 0.0004
386 DIZZINESS POSTURAL 4 0.0004
387 CHILLS 48 0.0004
388 GAIT DISTURBANCE 78 0.0004
389 BLINDNESS TRANSIENT 3 0.0004
390 MUSCULOSKELETAL DISCOMFORT 7 0.0004
391 NASAL POLYPS 2 0.0004
392 APPLICATION SITE BURN 2 0.0004
393 DIABETIC NEUROPATHY 2 0.0004
394 DRUG INTOLERANCE 39 0.0004
395 PHARYNGITIS 5 0.0004
396 HAIR COLOUR CHANGES 5 0.0004
397 HYPERAMMONAEMIA 2 0.0004
398 FLUID INTAKE REDUCED 2 0.0004
399 SWELLING FACE 26 0.0004
400 AORTIC ANEURYSM 3 0.0004
401 INSURANCE ISSUE 6 0.0004
402 LIP SWELLING 13 0.0004
403 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
404 HIATUS HERNIA 5 0.0004
405 BONE DISORDER 7 0.0004
406 RESPIRATORY TRACT INFECTION 10 0.0004
407 GASTROINTESTINAL INFLAMMATION 3 0.0004
408 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
409 PRODUCT ODOUR ABNORMAL 4 0.0004
410 THROAT IRRITATION 17 0.0004
411 BRONCHITIS 28 0.0004
412 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
413 BODY HEIGHT DECREASED 4 0.0004
414 FOOD POISONING 2 0.0004
415 FIBROMYALGIA 9 0.0004
416 PHARYNGITIS STREPTOCOCCAL 4 0.0004
417 LIMB INJURY 10 0.0004
418 BACK INJURY 4 0.0004
419 SLEEP APNOEA SYNDROME 7 0.0004
420 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
421 NONSPECIFIC REACTION 2 0.0004
422 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
423 PERIPHERAL COLDNESS 5 0.0004
424 HEART RATE INCREASED 36 0.0004
425 TOOTH FRACTURE 4 0.0004
426 VISUAL ACUITY REDUCED 12 0.0004
427 HYPOAESTHESIA 54 0.0004
428 ORAL DISCOMFORT 5 0.0004
429 FEELING COLD 10 0.0004
430 LOSS OF CONSCIOUSNESS 46 0.0004
431 INJECTION SITE PRURITUS 24 0.0004
432 MALNUTRITION 4 0.0004
433 NASAL CONGESTION 21 0.0004
434 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
435 RASH PAPULAR 8 0.0004
436 ABDOMINAL PAIN 83 0.0004
437 PRODUCTIVE COUGH 17 0.0004
438 BLOOD TEST ABNORMAL 5 0.0004
439 CANDIDA INFECTION 6 0.0004
440 HAEMATEMESIS 9 0.0004
441 HAEMATOCRIT DECREASED 7 0.0004
442 SWELLING 33 0.0004
443 FACIAL PARALYSIS 3 0.0004
444 NEUROLOGICAL SYMPTOM 2 0.0003
445 BLOOD MAGNESIUM DECREASED 3 0.0003
446 PRODUCT ADMINISTRATION ERROR 7 0.0003
447 SPINAL OSTEOARTHRITIS 3 0.0003
448 LUNG INFILTRATION 3 0.0003
449 LYMPHOCYTE COUNT DECREASED 6 0.0003
450 DECREASED INTEREST 2 0.0003
451 BRADYKINESIA 2 0.0003
452 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
453 SKIN HAEMORRHAGE 5 0.0003
454 BACTERAEMIA 4 0.0003
455 EPISTAXIS 25 0.0003
456 HEARING IMPAIRED 2 0.0003
457 OPTIC NEURITIS 3 0.0003
458 CONSTIPATION 72 0.0003
459 OSTEOPENIA 5 0.0003
460 INGUINAL HERNIA 2 0.0003
461 RHEUMATOID ARTHRITIS 37 0.0003
462 MUSCULAR WEAKNESS 37 0.0003
463 ECZEMA 17 0.0003
464 PERIPHERAL SWELLING 50 0.0003
465 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
466 MYALGIA 55 0.0003
467 PRODUCT DISTRIBUTION ISSUE 3 0.0003
468 MUSCULOSKELETAL CHEST PAIN 5 0.0003
469 BACK PAIN 75 0.0003
470 SOMNOLENCE 65 0.0003
471 PRODUCT USE IN UNAPPROVED INDICATION 80 0.0003
472 CYST 4 0.0003
473 BACTERIAL INFECTION 6 0.0003
474 TOOTH EXTRACTION 4 0.0003
475 SECRETION DISCHARGE 4 0.0003
476 NASAL DRYNESS 2 0.0003
477 SPINAL DISORDER 3 0.0003
478 PRODUCT DOSE OMISSION ISSUE 93 0.0003
479 PRODUCT COMPLAINT 8 0.0003
480 RED BLOOD CELL COUNT DECREASED 9 0.0003
481 RESPIRATORY TRACT CONGESTION 5 0.0003
482 HEADACHE 197 0.0003
483 COUGH 88 0.0003
484 ENTERITIS 2 0.0003
485 ROTATOR CUFF SYNDROME 4 0.0003
486 HYPERCHOLESTEROLAEMIA 3 0.0003
487 DYSPNOEA 175 0.0003
488 EXPOSURE VIA SKIN CONTACT 8 0.0003
489 BACK DISORDER 5 0.0003
490 RASH 133 0.0003
491 CHRONIC KIDNEY DISEASE 23 0.0003
492 MENINGITIS 2 0.0003
493 SKIN EXFOLIATION 25 0.0003
494 SINUS CONGESTION 4 0.0003
495 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
496 MOTOR DYSFUNCTION 3 0.0003
497 NEUTROPHIL COUNT INCREASED 3 0.0003
498 BLOOD TESTOSTERONE DECREASED 2 0.0003
499 EYE MOVEMENT DISORDER 2 0.0003
500 OROPHARYNGEAL PAIN 27 0.0003
501 HAIR GROWTH ABNORMAL 2 0.0003
502 ORTHOSTATIC HYPOTENSION 5 0.0003
503 DERMATITIS 6 0.0003
504 RASH MACULAR 10 0.0003
505 COVID-19 50 0.0003
506 DIZZINESS 142 0.0003
507 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
508 INCONTINENCE 3 0.0003
509 WEIGHT DECREASED 79 0.0003
510 ASTHENIA 106 0.0003
511 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
512 JOINT INJURY 6 0.0003
513 IMPAIRED QUALITY OF LIFE 4 0.0003
514 DERMATITIS BULLOUS 2 0.0003
515 HYPERTHYROIDISM 4 0.0003
516 TOOTHACHE 5 0.0003
517 BIPOLAR DISORDER 3 0.0003
518 PULMONARY THROMBOSIS 3 0.0003
519 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
520 GASTROENTERITIS 4 0.0003
521 WOUND INFECTION 3 0.0003
522 GASTROINTESTINAL PAIN 3 0.0003
523 EXTRA DOSE ADMINISTERED 11 0.0003
524 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
525 BLOOD PRESSURE DECREASED 18 0.0003
526 HYPOPHOSPHATAEMIA 2 0.0003
527 MEDICAL DEVICE COMPLICATION 2 0.0003
528 URINARY RETENTION 9 0.0003
529 DIPLOPIA 7 0.0003
530 FEELING DRUNK 2 0.0003
531 SKIN INFECTION 3 0.0003
532 BLOOD POTASSIUM DECREASED 8 0.0003
533 DERMATITIS ATOPIC 14 0.0003
534 APHASIA 8 0.0003
535 PALPITATIONS 31 0.0003
536 IMPAIRED DRIVING ABILITY 3 0.0003
537 URINARY TRACT INFECTION 45 0.0003
538 SKIN IRRITATION 12 0.0003
539 INFLUENZA 29 0.0003
540 DRUG EFFECT DECREASED 14 0.0003
541 PERICARDIAL EFFUSION 6 0.0003
542 PAIN 159 0.0003
543 DRY MOUTH 21 0.0003
544 THROAT TIGHTNESS 7 0.0003
545 ERUCTATION 5 0.0003
546 EJECTION FRACTION DECREASED 4 0.0003
547 APNOEA 2 0.0003
548 HAEMORRHOIDS 5 0.0003
549 NASOPHARYNGITIS 47 0.0003
550 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
551 COVID-19 PNEUMONIA 3 0.0003
552 DRUG SCREEN POSITIVE 2 0.0003
553 FATIGUE 197 0.0003
554 DISABILITY 5 0.0003
555 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
556 FURUNCLE 2 0.0003
557 MACULAR DEGENERATION 3 0.0003
558 MIOSIS 2 0.0002
559 MOVEMENT DISORDER 8 0.0002
560 VOMITING 117 0.0002
561 DIARRHOEA 160 0.0002
562 MYASTHENIA GRAVIS 2 0.0002
563 MENTAL IMPAIRMENT 6 0.0002
564 BLOOD POTASSIUM INCREASED 4 0.0002
565 DISCOMFORT 15 0.0002
566 INTENTIONAL DOSE OMISSION 7 0.0002
567 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
568 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
569 MUSCLE SPASTICITY 3 0.0002
570 CARDIOMEGALY 3 0.0002
571 SPINAL OPERATION 3 0.0002
572 ESCHERICHIA INFECTION 2 0.0002
573 HAIR DISORDER 2 0.0002
574 DYSGEUSIA 18 0.0002
575 MUSCLE INJURY 2 0.0002
576 NEEDLE ISSUE 7 0.0002
577 HEMIPLEGIA 2 0.0002
578 DYSPNOEA EXERTIONAL 9 0.0002
579 BRAIN OEDEMA 3 0.0002
580 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
581 RETCHING 5 0.0002
582 SCAR 4 0.0002
583 BLOOD GLUCOSE INCREASED 44 0.0002
584 IRRITABLE BOWEL SYNDROME 5 0.0002
585 ANOREXIA 3 0.0002
586 POOR QUALITY SLEEP 5 0.0002
587 FALL 77 0.0002
588 HYPERTENSION 49 0.0002
589 MUSCLE STRAIN 2 0.0002
590 HYSTERECTOMY 2 0.0002
591 PRODUCT DISPENSING ERROR 5 0.0002
592 FEELING ABNORMAL 55 0.0002
593 NAIL DISORDER 2 0.0002
594 ORAL CANDIDIASIS 3 0.0002
595 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
596 DRUG ERUPTION 4 0.0002
597 HAIR TEXTURE ABNORMAL 3 0.0002
598 NAUSEA 177 0.0002
599 QUALITY OF LIFE DECREASED 3 0.0002
600 ANAL INCONTINENCE 2 0.0002
601 PRODUCT TASTE ABNORMAL 3 0.0002
602 UVEITIS 3 0.0002
603 RESTLESS LEGS SYNDROME 4 0.0002
604 ABNORMAL DREAMS 6 0.0002
605 NERVE COMPRESSION 2 0.0002
606 INJECTION SITE MASS 8 0.0002
607 PROCEDURAL PAIN 6 0.0002
608 COORDINATION ABNORMAL 3 0.0002
609 CARPAL TUNNEL SYNDROME 3 0.0002
610 DIARRHOEA HAEMORRHAGIC 2 0.0002
611 DYSPEPSIA 21 0.0002
612 FLANK PAIN 2 0.0002
613 BLOOD SODIUM DECREASED 4 0.0002
614 LEUKAEMIA 2 0.0002
615 FLATULENCE 12 0.0002
616 BRONCHOSPASM 3 0.0002
617 MUSCULOSKELETAL DISORDER 4 0.0002
618 FUNGAL INFECTION 7 0.0002
619 SUBDURAL HAEMATOMA 3 0.0002
620 GAIT INABILITY 7 0.0002
621 HYPOTENSION 42 0.0002
622 HYPERSOMNIA 6 0.0002
623 LOWER LIMB FRACTURE 4 0.0002
624 AFFECT LABILITY 2 0.0002
625 HERNIA 4 0.0002
626 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
627 PRESYNCOPE 5 0.0002
628 AUTOIMMUNE DISORDER 2 0.0002
629 ORAL HERPES 4 0.0002
630 LUNG DISORDER 10 0.0002
631 KIDNEY INFECTION 4 0.0002
632 HEPATOMEGALY 2 0.0002
633 SINUS DISORDER 4 0.0002
634 IMMUNODEFICIENCY 3 0.0002
635 RESPIRATORY DISORDER 6 0.0002
636 AMNESIA 13 0.0002
637 SPINAL FRACTURE 4 0.0002
638 ECONOMIC PROBLEM 3 0.0002
639 PNEUMONIA 64 0.0002
640 VERTIGO 12 0.0002
641 DRY THROAT 2 0.0002
642 DRUG LEVEL DECREASED 2 0.0002
643 EPILEPSY 6 0.0002
644 MUSCLE SPASMS 36 0.0002
645 TINNITUS 9 0.0002
646 FEELING HOT 12 0.0002
647 INJECTION SITE RASH 6 0.0002
648 EUPHORIC MOOD 2 0.0002
649 PHARYNGEAL OEDEMA 3 0.0002
650 DEVICE RELATED INFECTION 3 0.0002
651 EAR DISCOMFORT 2 0.0002
652 INFLAMMATION 10 0.0002
653 INSOMNIA 51 0.0002
654 LETHARGY 11 0.0002
655 INJECTION SITE DISCOMFORT 2 0.0002
656 GASTROINTESTINAL DISORDER 17 0.0002
657 HALLUCINATION, VISUAL 4 0.0002
658 ADVERSE DRUG REACTION 17 0.0002
659 PNEUMOTHORAX 3 0.0002
660 HALLUCINATION, AUDITORY 3 0.0002
661 SCIATICA 3 0.0002
662 EATING DISORDER 4 0.0002
663 SURGERY 11 0.0002
664 LIVER FUNCTION TEST INCREASED 4 0.0002
665 PAIN OF SKIN 5 0.0002
666 DECREASED ACTIVITY 2 0.0002
667 BALANCE DISORDER 16 0.0002
668 PRURITUS GENERALISED 4 0.0002
669 PNEUMONITIS 5 0.0002
670 MOOD ALTERED 5 0.0002
671 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
672 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
673 LIVER DISORDER 8 0.0002
674 ARTHRALGIA 75 0.0002
675 MEDICATION ERROR 10 0.0002
676 TOOTH DISORDER 4 0.0002
677 NERVE INJURY 2 0.0002
678 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
679 BLOOD UREA INCREASED 3 0.0002
680 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
681 NEUROPATHY PERIPHERAL 17 0.0002
682 BLOOD CALCIUM DECREASED 2 0.0002
683 MICTURITION URGENCY 2 0.0002
684 INTERNAL HAEMORRHAGE 2 0.0002
685 PYREXIA 60 0.0002
686 INFECTION 25 0.0002
687 MUSCULOSKELETAL PAIN 9 0.0002
688 HEAD DISCOMFORT 3 0.0002
689 TREMOR 28 0.0002
690 RENAL INJURY 5 0.0002
691 ISCHAEMIC STROKE 3 0.0002
692 PRODUCT PRESCRIBING ERROR 4 0.0002
693 CATARACT 10 0.0002
694 ACCIDENT 2 0.0002
695 FLUSHING 17 0.0002
696 GOUT 3 0.0002
697 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
698 LOCALISED INFECTION 4 0.0002
699 DRUG EFFECT INCOMPLETE 6 0.0002
700 ANXIETY 47 0.0002
701 ABDOMINAL PAIN UPPER 34 0.0002
702 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
703 ADRENAL INSUFFICIENCY 2 0.0002
704 HYPERGLYCAEMIA 6 0.0002
705 UNDERDOSE 12 0.0002
706 ACCIDENTAL OVERDOSE 6 0.0002
707 NO THERAPEUTIC RESPONSE 2 0.0002
708 INJECTION SITE URTICARIA 4 0.0002
709 WEIGHT INCREASED 36 0.0002
710 OXYGEN SATURATION DECREASED 9 0.0002
711 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
712 PRODUCT USE ISSUE 30 0.0002
713 DYSARTHRIA 6 0.0002
714 HOT FLUSH 12 0.0002
715 UNEVALUABLE EVENT 12 0.0002
716 HYPOCALCAEMIA 3 0.0002
717 DEPRESSION 36 0.0002
718 MUSCLE ATROPHY 2 0.0002
719 INJECTION SITE IRRITATION 2 0.0002
720 CYSTITIS 5 0.0002
721 HERPES ZOSTER 9 0.0002
722 HYPOPHAGIA 4 0.0002
723 POST PROCEDURAL COMPLICATION 3 0.0002
724 OEDEMA PERIPHERAL 19 0.0002
725 UNRESPONSIVE TO STIMULI 4 0.0002
726 SKIN ULCER 4 0.0002
727 DYSTONIA 3 0.0002
728 SKIN FISSURES 3 0.0002
729 BLOOD CREATININE INCREASED 10 0.0002
730 NEPHROLITHIASIS 7 0.0002
731 INCORRECT PRODUCT STORAGE 2 0.0002
732 IMMUNE SYSTEM DISORDER 2 0.0002
733 HYPOKALAEMIA 7 0.0002
734 BLOOD PRESSURE ABNORMAL 3 0.0002
735 BLOOD CHOLESTEROL INCREASED 7 0.0002
736 PAIN IN EXTREMITY 44 0.0001
737 MALIGNANT MELANOMA 2 0.0001
738 JOINT RANGE OF MOTION DECREASED 2 0.0001
739 PLEURAL EFFUSION 9 0.0001
740 SEIZURE 17 0.0001
741 PALLOR 4 0.0001
742 IMPAIRED GASTRIC EMPTYING 2 0.0001
743 GINGIVAL BLEEDING 2 0.0001
744 CORONARY ARTERY OCCLUSION 2 0.0001
745 CHEST PAIN 27 0.0001
746 GASTRIC DISORDER 5 0.0001
747 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
748 RESPIRATORY ARREST 4 0.0001
749 POLLAKIURIA 6 0.0001
750 MALAISE 63 0.0001
751 HUNGER 2 0.0001
752 ROAD TRAFFIC ACCIDENT 6 0.0001
753 MASS 2 0.0001
754 RENAL FAILURE 19 0.0001
755 DEVICE OCCLUSION 2 0.0001
756 ADVERSE EVENT 13 0.0001
757 HYPOACUSIS 6 0.0001
758 SKIN CANCER 3 0.0001
759 CELLULITIS 7 0.0001
760 ANOSMIA 2 0.0001
761 HYPOKINESIA 2 0.0001
762 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
763 FLUID RETENTION 7 0.0001
764 LIVER FUNCTION TEST ABNORMAL 4 0.0001
765 MELAENA 3 0.0001
766 APPLICATION SITE PAIN 3 0.0001
767 DYSURIA 5 0.0001
768 INFUSION RELATED REACTION 9 0.0001
769 LABORATORY TEST ABNORMAL 4 0.0001
770 PSYCHOTIC DISORDER 4 0.0001
771 CARDIOMYOPATHY 2 0.0001
772 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
773 RASH MACULO-PAPULAR 3 0.0001
774 ABDOMINAL DISTENSION 14 0.0001
775 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 27 0.0001
776 CHROMATURIA 3 0.0001
777 HEART RATE IRREGULAR 3 0.0001
778 DEVICE FAILURE 2 0.0001
779 DRUG DISPENSING ERROR 2 0.0001
780 INJECTION SITE REACTION 9 0.0001
781 MUSCLE TWITCHING 3 0.0001
782 RENAL DISORDER 6 0.0001
783 LUNG INFECTION 2 0.0001
784 COGNITIVE DISORDER 6 0.0001
785 BASAL CELL CARCINOMA 2 0.0001
786 NERVOUS SYSTEM DISORDER 4 0.0001
787 CYANOSIS 2 0.0001
788 PARAESTHESIA 20 0.0001
789 HEAD INJURY 4 0.0001
790 PULMONARY EMBOLISM 12 0.0001
791 HYPOTHYROIDISM 4 0.0001
792 BLOOD GLUCOSE DECREASED 6 0.0001
793 HIP FRACTURE 4 0.0001
794 ACUTE KIDNEY INJURY 19 0.0001
795 NIGHT SWEATS 4 0.0001
796 HYPOGLYCAEMIA 6 0.0001
797 NEURALGIA 3 0.0001
798 LIVER INJURY 3 0.0001
799 STAPHYLOCOCCAL INFECTION 4 0.0001
800 AGEUSIA 3 0.0001
801 TYPE 2 DIABETES MELLITUS 4 0.0001
802 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
803 DIABETES MELLITUS 9 0.0001
804 INJECTION SITE SWELLING 9 0.0001
805 THERAPY CESSATION 6 0.0001
806 HAEMOGLOBIN DECREASED 12 0.0001
807 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
808 MEMORY IMPAIRMENT 16 0.0001
809 IRRITABILITY 7 0.0001
810 RECTAL HAEMORRHAGE 5 0.0001
811 RASH GENERALISED 3 0.0001
812 HAEMATOMA 3 0.0001
813 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
814 THERAPEUTIC RESPONSE DECREASED 7 0.0001
815 STOMATITIS 7 0.0001
816 ANAEMIA 22 0.0001
817 OFF LABEL USE 101 0.0001
818 LOCAL SWELLING 2 0.0001
819 JOINT STIFFNESS 3 0.0001
820 DEVICE USE ISSUE 2 0.0001
821 ANHEDONIA 3 0.0001
822 HEART RATE DECREASED 4 0.0001
823 INCORRECT DOSE ADMINISTERED 26 0.0001
824 INJURY 8 0.0001
825 HYPOXIA 4 0.0001
826 DEPRESSED MOOD 6 0.0001
827 COLD SWEAT 2 0.0001
828 SLEEP DISORDER 8 0.0001
829 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
830 PLATELET COUNT DECREASED 12 0.0001
831 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
832 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
833 THROMBOSIS 9 0.0001
834 FEAR 3 0.0001
835 DISTURBANCE IN ATTENTION 6 0.0001
836 FREQUENT BOWEL MOVEMENTS 3 0.0001
837 BLOOD BILIRUBIN INCREASED 3 0.0001
838 OSTEOMYELITIS 2 0.0001
839 SYNCOPE 11 0.0001
840 PANIC ATTACK 4 0.0001
841 SKIN LESION 3 0.0001
842 RESTLESSNESS 4 0.0001
843 AGITATION 8 0.0001
844 SKIN DISCOLOURATION 5 0.0001
845 DIVERTICULITIS 3 0.0001
846 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
847 DECREASED APPETITE 25 0.0001
848 AGRANULOCYTOSIS 2 0.0001
849 CARDIAC DISORDER 10 0.0001
850 FRACTURE 2 0.0001
851 FEBRILE NEUTROPENIA 7 0.0001
852 COLITIS 4 0.0001
853 BLOOD URINE PRESENT 2 0.0001
854 GASTRIC ULCER 2 0.0001
855 DISEASE RECURRENCE 5 0.0001
856 FEELING JITTERY 2 0.0001
857 ANGINA PECTORIS 3 0.0001
858 ACUTE RESPIRATORY FAILURE 2 0.0001
859 DYSSTASIA 3 0.0001
860 CHOKING 2 0.0001
861 MENORRHAGIA 2 0.0001
862 ACUTE MYOCARDIAL INFARCTION 3 0.0001
863 INJECTION SITE PAIN 31 0.0001
864 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
865 FULL BLOOD COUNT DECREASED 2 0.0001
866 CORONARY ARTERY DISEASE 3 0.0001
867 SUICIDE ATTEMPT 6 0.0001
868 ILL-DEFINED DISORDER 6 0.0001
869 SEPSIS 11 0.0001
870 FEEDING DISORDER 2 0.0001
871 BODY TEMPERATURE INCREASED 2 0.0001
872 THERAPY INTERRUPTED 7 0.0001
873 SKIN BURNING SENSATION 7 0.0001
874 INJECTION SITE WARMTH 2 0.0001
875 INFLUENZA LIKE ILLNESS 8 0.0001
876 LIMB DISCOMFORT 3 0.0001
877 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
878 NERVOUSNESS 5 0.0001
879 KNEE ARTHROPLASTY 2 0.0001
880 MOOD SWINGS 3 0.0001
881 METABOLIC ACIDOSIS 3 0.0001
882 IMPAIRED WORK ABILITY 2 0.0001
883 ATRIAL FIBRILLATION 9 0.0001
884 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
885 PRODUCT DOSE OMISSION 6 0.0001
886 ALOPECIA 18 0.0001
887 TREATMENT NONCOMPLIANCE 5 0.0001
888 INTENTIONAL PRODUCT MISUSE 8 0.0001
889 IMPAIRED HEALING 3 0.0001
890 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
891 TACHYCARDIA 8 0.0001
892 HEPATOTOXICITY 2 0.0001
893 GLOSSODYNIA 2 0.0001
894 THERAPY NON-RESPONDER 4 0.0001
895 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
896 HYPONATRAEMIA 5 0.0001
897 INJECTION SITE ERYTHEMA 11 0.0001
898 NO ADVERSE EVENT 16 0.0001
899 HEPATIC ENZYME INCREASED 6 0.0001
900 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
901 INJECTION SITE BRUISING 7 0.0001
902 LYMPHADENOPATHY 3 0.0001
903 CRYING 3 0.0001
904 DEHYDRATION 11 0.0001
905 C-REACTIVE PROTEIN INCREASED 3 0.0001
906 CEREBRAL INFARCTION 2 0.0001
907 ENCEPHALOPATHY 2 0.0001
908 ABASIA 2 0.0001
909 OSTEONECROSIS OF JAW 2 0.0001
910 PRODUCT STORAGE ERROR 7 0.0001
911 HEPATITIS 2 0.0001
912 ERECTILE DYSFUNCTION 2 0.0001
913 PLASMA CELL MYELOMA 3 0.0001
914 DEAFNESS 2 0.0001
915 SUICIDAL IDEATION 7 0.0001
916 DISEASE PROGRESSION 9 0.0001
917 INJECTION SITE HAEMORRHAGE 6 0.0001
918 ABORTION SPONTANEOUS 3 0.0001
919 CARDIAC FAILURE 6 0.0001
920 NEUTROPHIL COUNT DECREASED 3 0.0001
921 HAEMATOCHEZIA 4 0.0001
922 MENTAL STATUS CHANGES 2 0.0001
923 RHABDOMYOLYSIS 3 0.0001
924 HAEMOPTYSIS 2 0.0001
925 THROMBOCYTOPENIA 8 0.0001
926 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
927 HYPERHIDROSIS 9 0.0001
928 DEVICE LEAKAGE 3 0.0001
929 MENTAL DISORDER 3 0.0001
930 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
931 COLITIS ULCERATIVE 3 0.0001
932 HAEMORRHAGE 7 0.0001
933 DEVICE ISSUE 6 0.0001
934 HEPATIC FAILURE 2 0.0001
935 EMOTIONAL DISTRESS 8 0.0001
936 DRUG ADMINISTRATION ERROR 2 0.0001
937 EMOTIONAL DISORDER 2 0.0001
938 FEMUR FRACTURE 2 0.0001
939 ARRHYTHMIA 3 0.0001
940 CARDIAC FAILURE CONGESTIVE 5 0.0001
941 CHOLELITHIASIS 2 0.0001
942 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
943 LEUKOPENIA 3 0.0001
944 NEOPLASM MALIGNANT 4 0.0001
945 RENAL IMPAIRMENT 5 0.0001
946 TOXICITY TO VARIOUS AGENTS 10 0.0001
947 NIGHTMARE 2 0.0001
948 DELIRIUM 2 0.0001
949 HYPERKALAEMIA 2 0.0001
950 DEVICE MALFUNCTION 4 0.0001
951 PANCREATITIS 3 0.0001
952 BRADYCARDIA 3 0.0001
953 CONFUSIONAL STATE 9 0.0001
954 RESPIRATORY FAILURE 4 0.0001
955 ARTHROPATHY 3 0.0001
956 BREAST CANCER 5 0.0001
957 HEPATIC FUNCTION ABNORMAL 2 0.0001
958 ACNE 4 0.0001
959 CONVULSION 3 0.0001
960 PRODUCT SUBSTITUTION ISSUE 3 0.0001
961 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
962 ABNORMAL BEHAVIOUR 2 0.0001
963 DISORIENTATION 2 0.0001
964 DEVICE BREAKAGE 2 0.0000
965 BLINDNESS 2 0.0000
966 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
967 EXPOSURE DURING PREGNANCY 3 0.0000
968 DRUG ABUSE 4 0.0000
969 CARDIO-RESPIRATORY ARREST 2 0.0000
970 OVERDOSE 10 0.0000
971 DEEP VEIN THROMBOSIS 3 0.0000
972 DEVICE DISLOCATION 2 0.0000
973 PSORIASIS 6 0.0000
974 MYOCARDIAL INFARCTION 8 0.0000
975 DRUG WITHDRAWAL SYNDROME 4 0.0000
976 DRUG INTERACTION 7 0.0000
977 CEREBROVASCULAR ACCIDENT 7 0.0000
978 HOSPITALISATION 6 0.0000
979 NEUTROPENIA 5 0.0000
980 CARDIAC ARREST 3 0.0000
981 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
982 INTENTIONAL OVERDOSE 2 0.0000
983 DEVICE DIFFICULT TO USE 2 0.0000
984 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
985 DEATH 24 0.0000
986 DRUG DOSE OMISSION BY DEVICE 2 0.0000
987 DRUG DEPENDENCE 4 0.0000
988 DRUG DOSE OMISSION 4 0.0000